Literature DB >> 6249892

Experimental autoimmune myasthenia gravis.

J Lindstrom.   

Abstract

Injection of animals with purified acetylcholine receptor in complete Freund's adjuvant causes development of antibodies which crossreact with receptors in muscle. The crossreacting antibodies impair neuromuscular transmission. Animals with experimental autoimmune myasthenia gravis (EAMG) are excellent models for studying the complex mechanisms by which the autoimmune response to receptor in myasthenia gravis causes muscle weakness. This review first briefly describes the discovery of EAMG. Then, to provide the necessary perspective, receptor structure and function and properties of anti-receptor antibodies are discussed, followed by a brief review of the pathological mechanisms in EAMG.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6249892      PMCID: PMC490624          DOI: 10.1136/jnnp.43.7.568

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  70 in total

1.  Neuromuscular transmission after immunization against acetylcholine receptors.

Authors:  D P Green; R Miledi; A Vincent
Journal:  Proc R Soc Lond B Biol Sci       Date:  1975-04-29

2.  Studies on purified eel acetylcholine receptor and anti-acetylcholine receptor antibody.

Authors:  J Patrick; J Lindstrom; B Culp; J McMillan
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

3.  Influence of denervation on localization of neurotoxins from clapid venoms in rat diaphragm.

Authors:  C Y Lee; L F Tseng; T H Chiu
Journal:  Nature       Date:  1967-09-09       Impact factor: 49.962

4.  Autoimmune response to acetylcholine receptor.

Authors:  J Patrick; J Lindstrom
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

5.  Studies on the cholinergic receptor protein of Electrophorus electricus. I. An assay in vitro for the cholinergic receptor site and solubilization of the receptor protein from electric tissue.

Authors:  J P Changeux; J C Meunier; M Huchet
Journal:  Mol Pharmacol       Date:  1971-09       Impact factor: 4.436

6.  Photo-affinity labeling of specific acetylcholine-binding sites on membranes.

Authors:  H Kiefer; J Lindstrom; E S Lennox; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

7.  Immunological characterisation of the cholinergic receptor protein from Electrophorus electricus.

Authors:  H Sugiyama; P Benda; J C Meunier; J P Changeux
Journal:  FEBS Lett       Date:  1973-09-01       Impact factor: 4.124

8.  Appearance of acetylcholine receptors during differentiation of a myogenic cell line.

Authors:  J Patrick; S F Heinemann; J Lindstrom; D Schubert; J H Steinbach
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

9.  Localization of acetylcholine receptor by 125I-labeled alpha-bungarotoxin binding at mouse motor endplates.

Authors:  H C Fertuck; M M Salpeter
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.

Authors:  V A Lennon; J M Lindstrom; M E Seybold
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Experimental autoimmune myositis in SJL/J mice.

Authors:  N L Rosenberg; S P Ringel; B L Kotzin
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

Review 3.  Animal models of myasthenia gravis: utility and limitations.

Authors:  Renato Mantegazza; Chiara Cordiglieri; Alessandra Consonni; Fulvio Baggi
Journal:  Int J Gen Med       Date:  2016-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.